Literature DB >> 24158640

Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis.

Eliana Rulli1, Elena Biagioli1, Ivano Riva2, Giovanni Gambirasio2, Irene De Simone1, Irene Floriani1, Luciano Quaranta2.   

Abstract

IMPORTANCE: To date, only a few studies have directly compared nonpenetrating surgery (NPS) and trabeculectomy (TE). Therefore, there is no strong evidence as to which surgical technique leads to the best results in terms of ocular hypotensive effect and safety.
OBJECTIVE: To compare the hypotensive effect and safety of NPS and TE in terms of intraocular pressure (IOP) reduction and incidence of complications. DATA SOURCES: The MEDLINE and EMBASE databases were searched for studies potentially eligible in any language published up to March 31, 2013. STUDY SELECTION: Systematic review and meta-analysis of comparative studies of 2 or more surgical techniques (1 of which had to be TE), including patients with open-angle glaucoma. DATA EXTRACTION AND SYNTHESIS: The considered interventions were TE, deep sclerectomy (DS), viscocanalostomy, and canaloplasty. MAIN OUTCOMES AND MEASURES: The primary outcome was the mean between-group difference in the reduction in diurnal IOP from baseline to the 6- or 12-month follow-up evaluation. We also considered the incidence of complications, expressed as relative risk.
RESULTS: Eighteen articles, accounting for 20 comparisons, were selected for data extraction and analysis. Analysis of the 6-month follow-up data showed that the pooled estimate of the mean between-group difference was -2.15 mm Hg (95% CI, -2.85 to -1.44) in favor of TE. There was no difference between the NPS subgroups. In the subgroup antimetabolite analysis, the addition of mitomycin C to TE and DS decreased the difference in the reduction in IOP (TE and DS without mitomycin C: -2.65 mm Hg [95% CI, -3.90 to -1.39]; TE and DS with mitomycin C: -0.83 mm Hg [95% CI, -2.40 to 0.74]). In the subgroup analysis by implant addition, no significant difference induced by DS with or without drainage devices was detected (test for subgroup differences: χ(2)(1) = 0.24; P = .62). The absolute risk of hypotony, choroidal effusion, cataract, and flat or shallow anterior chamber was higher in the TE group than in the NPS group. CONCLUSIONS AND RELEVANCE: Trabeculectomy seems to be the most effective surgical procedure for reducing IOP in patients with open-angle glaucoma. However, as expected, it was associated with a higher incidence of complications when compared with NPS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24158640     DOI: 10.1001/jamaophthalmol.2013.5059

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  84 in total

1.  Modified canaloplasty with suprachoroidal drainage versus conventional canaloplasty-1-year results.

Authors:  Anna-Maria Seuthe; Ciprian Ivanescu; Stephan Leers; Karl Boden; Kai Januschowski; Peter Szurman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-05-10       Impact factor: 3.117

2.  Long-term efficacy of deep sclerectomy in Posner-Schlossman syndrome.

Authors:  Fiamma Campana; Guido Caramello; Laura Dallorto; Teresa Rolle
Journal:  BMJ Case Rep       Date:  2015-01-23

Review 3.  [Trabeculectomy versus canaloplasty].

Authors:  J Matlach; T Klink
Journal:  Ophthalmologe       Date:  2015-04       Impact factor: 1.059

4.  Comparison of canaloplasty and trabeculectomy for open angle glaucoma: a Meta-analysis.

Authors:  Zhong-Jing Lin; Shuo Xu; Shou-Yue Huang; Xiao-Bin Zhang; Yi-Sheng Zhong
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

5.  Longitudinal change in choroidal thickness after trabeculectomy in primary open-angle glaucoma patients.

Authors:  Munemitsu Yoshikawa; Tadamichi Akagi; Hideo Nakanishi; Hanako Ohashi Ikeda; Satoshi Morooka; Hiroshi Yamada; Tomoko Hasegawa; Yuto Iida; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2016-10-03       Impact factor: 2.447

6.  Non-penetrating glaucoma surgery for advanced open-angle glaucoma.

Authors:  David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-18       Impact factor: 3.117

7.  One-month IOP in mitomycin C-augmented trabeculectomy can predict long-term IOP control in chronic primary angle-closure glaucoma.

Authors:  Chengguo Zuo; Shufen Lin; Keling Wu; Ruowen Gong; Yafen Liu; Mingkai Lin; Jian Ge
Journal:  Int Ophthalmol       Date:  2019-01-24       Impact factor: 2.031

8.  Clinical outcomes after Ex-PRESS glaucoma shunt versus non-penetrating deep sclerectomy: two-year follow-up.

Authors:  Beatriz Puerto; Cristina López-Caballero; Carmen Sánchez-Sánchez; Noelia Oblanca; Vanesa Blázquez; Inés Contreras
Journal:  Int Ophthalmol       Date:  2017-11-24       Impact factor: 2.031

9.  Five-year results of non-penetrating deep sclerectomy with demineralized cancellous bone xenogenically derived collagen glaucoma implant.

Authors:  Natalia S Anisimova; Lisa B Arbisser; Sergey I Anisimov; Lusine L Arutyunyan; Natalya F Shilova; Gilyana Bashaeva; Roman V Kirtaev; Svetlana Yu Anisimova
Journal:  Int Ophthalmol       Date:  2021-03-03       Impact factor: 2.031

10.  Baerveldt tube implantation following failed deep sclerectomy versus repeat deep sclerectomy.

Authors:  C Bergin; A Petrovic; A Mermoud; E Ravinet; E Sharkawi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-31       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.